| |
| |
| |
| |
| |
| | | | |
|
PR:P51587 | breast cancer type 2 susceptibility protein (human) | | | | | |
| | | | | |
|
PR:000078580 | breast cancer type 2 susceptibility protein cysteinylated 1 (human) | | | | | |
| | | | | |
|
PR:000066432 | breast cancer type 2 susceptibility protein deaminated 1 (human) | | | | | |
| | | | | |
|
PR:000066492 | breast cancer type 2 susceptibility protein deaminated 2 (human) | | | | | |
| | | | | |
|
PR:000072027 | breast cancer type 2 susceptibility protein deaminated 3 (human) | | | | | |
| | | | | |
|
PR:000073005 | breast cancer type 2 susceptibility protein deaminated 4 (human) | | | | | |
| | | | | |
|
PR:000067955 | breast cancer type 2 susceptibility protein methylated 1 (human) | | | | | |
| | | | | |
|
PR:000070934 | breast cancer type 2 susceptibility protein methylated 2 (human) | | | | | |
| | | | | |
|
PR:000072752 | breast cancer type 2 susceptibility protein methylated 3 (human) | | | | | |
| | | | | |
|
PR:000080574 | breast cancer type 2 susceptibility protein methylated 4 (human) | | | | | |
| | | | | |
|
PR:000035486 | breast cancer type 2 susceptibility protein phosphorylated 1 (human) | | | | | |
| | | | | |
|
PR:000045544 | breast cancer type 2 susceptibility protein phosphorylated 2 (human) | | | | | |
| | | | | |
|
PR:000045817 | breast cancer type 2 susceptibility protein phosphorylated 3 (human) | | | | | |
| | | | | |
|
PR:000075561 | breast cancer type 2 susceptibility protein phosphorylated 4 (human) | | | | | |
| | | | | |
|
PR:000061485 | breast cancer type 2 susceptibility protein sequence variant C1200* (human) | | | | | |
| | | | | |
|
PR:000060791 | breast cancer type 2 susceptibility protein sequence variant C2422* (human) | | | | | |
| | | | | |
|
PR:000060763 | breast cancer type 2 susceptibility protein sequence variant C711* (human) | | | | | |
| | | | | |
|
PR:000064582 | breast cancer type 2 susceptibility protein sequence variant D2723G (human) | | | | | |
| | | | | |
|
PR:000062322 | breast cancer type 2 susceptibility protein sequence variant D2723H (human) | | | | | |
| | | | | |
|
PR:000063423 | breast cancer type 2 susceptibility protein sequence variant E1113* (human) | | | | | |
| | | | | |
|
PR:000060427 | breast cancer type 2 susceptibility protein sequence variant E1120* (human) | | | | | |
| | | | | |
|
PR:000063272 | breast cancer type 2 susceptibility protein sequence variant E1276* (human) | | | | | |
| | | | | |
|
PR:000063067 | breast cancer type 2 susceptibility protein sequence variant E1285* (human) | | | | | |
| | | | | |
|
PR:000064098 | breast cancer type 2 susceptibility protein sequence variant E1441* (human) | | | | | |
| | | | | |
|
PR:000061354 | breast cancer type 2 susceptibility protein sequence variant E1493* (human) | | | | | |
| | | | | |
|
PR:000061047 | breast cancer type 2 susceptibility protein sequence variant E1514* (human) | | | | | |
| | | | | |
|
PR:000063561 | breast cancer type 2 susceptibility protein sequence variant E1518* (human) | | | | | |
| | | | | |
|
PR:000063667 | breast cancer type 2 susceptibility protein sequence variant E1555* (human) | | | | | |
| | | | | |
|
PR:000063320 | breast cancer type 2 susceptibility protein sequence variant E1581* (human) | | | | | |
| | | | | |
|
PR:000062045 | breast cancer type 2 susceptibility protein sequence variant E1593* (human) | | | | | |
| | | | | |
|
PR:000062761 | breast cancer type 2 susceptibility protein sequence variant E1646* (human) | | | | | |
| | | | | |
|
PR:000061436 | breast cancer type 2 susceptibility protein sequence variant E1688* (human) | | | | | |
| | | | | |
|
PR:000061921 | breast cancer type 2 susceptibility protein sequence variant E1717* (human) | | | | | |
| | | | | |
|
PR:000061964 | breast cancer type 2 susceptibility protein sequence variant E1812* (human) | | | | | |
| | | | | |
|
PR:000064420 | breast cancer type 2 susceptibility protein sequence variant E187* (human) | | | | | |
| | | | | |
|
PR:000060549 | breast cancer type 2 susceptibility protein sequence variant E2028* (human) | | | | | |
| | | | | |
|
PR:000063385 | breast cancer type 2 susceptibility protein sequence variant E2129* (human) | | | | | |
| | | | | |
|
PR:000061932 | breast cancer type 2 susceptibility protein sequence variant E2474* (human) | | | | | |
| | | | | |
|
PR:000063404 | breast cancer type 2 susceptibility protein sequence variant E2476* (human) | | | | | |
| | | | | |
|
PR:000064389 | breast cancer type 2 susceptibility protein sequence variant E2571* (human) | | | | | |
| | | | | |
|
PR:000064088 | breast cancer type 2 susceptibility protein sequence variant E2599* (human) | | | | | |
| | | | | |
|
PR:000061248 | breast cancer type 2 susceptibility protein sequence variant E2663Q (human) | | | | | |
| | | | | |
|
PR:000063327 | breast cancer type 2 susceptibility protein sequence variant E2663V (human) | | | | | |
| | | | | |
|
PR:000061057 | breast cancer type 2 susceptibility protein sequence variant E2847* (human) | | | | | |
| | | | | |
|
PR:000062866 | breast cancer type 2 susceptibility protein sequence variant E2863* (human) | | | | | |
| | | | | |
|
PR:000061413 | breast cancer type 2 susceptibility protein sequence variant E2872* (human) | | | | | |
| | | | | |
|
PR:000060393 | breast cancer type 2 susceptibility protein sequence variant E2906* (human) | | | | | |
| | | | | |
|
PR:000063289 | breast cancer type 2 susceptibility protein sequence variant E294* (human) | | | | | |
| | | | | |
|
PR:000062546 | breast cancer type 2 susceptibility protein sequence variant E2956* (human) | | | | | |
| | | | | |
|
PR:000063010 | breast cancer type 2 susceptibility protein sequence variant E2959* (human) | | | | | |
| | | | | |
|
PR:000063759 | breast cancer type 2 susceptibility protein sequence variant E305* (human) | | | | | |
| | | | | |
|
PR:000060466 | breast cancer type 2 susceptibility protein sequence variant E3053* (human) | | | | | |
| | | | | |
|
PR:000063240 | breast cancer type 2 susceptibility protein sequence variant E3071* (human) | | | | | |
| | | | | |
|
PR:000062082 | breast cancer type 2 susceptibility protein sequence variant E3111* (human) | | | | | |
| | | | | |
|
PR:000062124 | breast cancer type 2 susceptibility protein sequence variant E409* (human) | | | | | |
| | | | | |
|
PR:000061267 | breast cancer type 2 susceptibility protein sequence variant E475* (human) | | | | | |
| | | | | |
|
PR:000062133 | breast cancer type 2 susceptibility protein sequence variant E510* (human) | | | | | |
| | | | | |
|
PR:000062635 | breast cancer type 2 susceptibility protein sequence variant E654* (human) | | | | | |
| | | | | |
|
PR:000061209 | breast cancer type 2 susceptibility protein sequence variant E808* (human) | | | | | |
| | | | | |
|
PR:000062820 | breast cancer type 2 susceptibility protein sequence variant E826* (human) | | | | | |
| | | | | |
|
PR:000060516 | breast cancer type 2 susceptibility protein sequence variant E865* (human) | | | | | |
| | | | | |
|
PR:000061914 | breast cancer type 2 susceptibility protein sequence variant E866* (human) | | | | | |
| | | | | |
|
PR:000064128 | breast cancer type 2 susceptibility protein sequence variant E880* (human) | | | | | |
| | | | | |
|
PR:000063540 | breast cancer type 2 susceptibility protein sequence variant E897* (human) | | | | | |
| | | | | |
|
PR:000060571 | breast cancer type 2 susceptibility protein sequence variant E97* (human) | | | | | |
| | | | | |
|
PR:000063225 | breast cancer type 2 susceptibility protein sequence variant F1182* (human) | | | | | |
| | | | | |
|
PR:000063072 | breast cancer type 2 susceptibility protein sequence variant G1006* (human) | | | | | |
| | | | | |
|
PR:000064169 | breast cancer type 2 susceptibility protein sequence variant G106* (human) | | | | | |
| | | | | |
|
PR:000063713 | breast cancer type 2 susceptibility protein sequence variant G1122* (human) | | | | | |
| | | | | |
|
PR:000060354 | breast cancer type 2 susceptibility protein sequence variant G1529E (human) | | | | | |
| | | | | |
|
PR:000062990 | breast cancer type 2 susceptibility protein sequence variant G1529R (human) | | | | | |
| | | | | |
|
PR:000062704 | breast cancer type 2 susceptibility protein sequence variant G2281* (human) | | | | | |
| | | | | |
|
PR:000063222 | breast cancer type 2 susceptibility protein sequence variant G2593* (human) | | | | | |
| | | | | |
|
PR:000063243 | breast cancer type 2 susceptibility protein sequence variant G25R (human) | | | | | |
| | | | | |
|
PR:000062708 | breast cancer type 2 susceptibility protein sequence variant G25V (human) | | | | | |
| | | | | |
|
PR:000063424 | breast cancer type 2 susceptibility protein sequence variant G2748D (human) | | | | | |
| | | | | |
|
PR:000062147 | breast cancer type 2 susceptibility protein sequence variant G2837* (human) | | | | | |
| | | | | |
|
PR:000063781 | breast cancer type 2 susceptibility protein sequence variant G4* (human) | | | | | |
| | | | | |
|
PR:000064571 | breast cancer type 2 susceptibility protein sequence variant G405* (human) | | | | | |
| | | | | |
|
PR:000063301 | breast cancer type 2 susceptibility protein sequence variant G561* (human) | | | | | |
| | | | | |
|
PR:000061763 | breast cancer type 2 susceptibility protein sequence variant G904* (human) | | | | | |
| | | | | |
|
PR:000060539 | breast cancer type 2 susceptibility protein sequence variant G934* (human) | | | | | |
| | | | | |
|
PR:000063387 | breast cancer type 2 susceptibility protein sequence variant G995* (human) | | | | | |
| | | | | |
|
PR:000061772 | breast cancer type 2 susceptibility protein sequence variant I1258* (human) | | | | | |
| | | | | |
|
PR:000060956 | breast cancer type 2 susceptibility protein sequence variant I2627F (human) | | | | | |
| | | | | |
|
PR:000061755 | breast cancer type 2 susceptibility protein sequence variant K1082* (human) | | | | | |
| | | | | |
|
PR:000063737 | breast cancer type 2 susceptibility protein sequence variant K1453* (human) | | | | | |
| | | | | |
|
PR:000061343 | breast cancer type 2 susceptibility protein sequence variant K1515* (human) | | | | | |
| | | | | |
|
PR:000062063 | breast cancer type 2 susceptibility protein sequence variant K1649* (human) | | | | | |
| | | | | |
|
PR:000064473 | breast cancer type 2 susceptibility protein sequence variant K178* (human) | | | | | |
| | | | | |
|
PR:000060489 | breast cancer type 2 susceptibility protein sequence variant K1860* (human) | | | | | |
| | | | | |
|
PR:000062834 | breast cancer type 2 susceptibility protein sequence variant K1872* (human) | | | | | |
| | | | | |
|
PR:000061572 | breast cancer type 2 susceptibility protein sequence variant K230* (human) | | | | | |
| | | | | |
|
PR:000061829 | breast cancer type 2 susceptibility protein sequence variant K2392* (human) | | | | | |
| | | | | |
|
PR:000060829 | breast cancer type 2 susceptibility protein sequence variant K2555* (human) | | | | | |
| | | | | |
|
PR:000062918 | breast cancer type 2 susceptibility protein sequence variant K2570* (human) | | | | | |
| | | | | |
|
PR:000061622 | breast cancer type 2 susceptibility protein sequence variant K3015* (human) | | | | | |
| | | | | |
|
PR:000064511 | breast cancer type 2 susceptibility protein sequence variant K3032* (human) | | | | | |
| | | | | |
|
PR:000064081 | breast cancer type 2 susceptibility protein sequence variant K467* (human) | | | | | |
| | | | | |
|
PR:000063389 | breast cancer type 2 susceptibility protein sequence variant K604* (human) | | | | | |
| | | | | |
|
PR:000064320 | breast cancer type 2 susceptibility protein sequence variant K944* (human) | | | | | |
| | | | | |
|
PR:000063657 | breast cancer type 2 susceptibility protein sequence variant L105* (human) | | | | | |
| | | | | |
|
PR:000060692 | breast cancer type 2 susceptibility protein sequence variant L1208* (human) | | | | | |
| | | | | |
|
PR:000060282 | breast cancer type 2 susceptibility protein sequence variant L1740* (human) | | | | | |
| | | | | |
|
PR:000062484 | breast cancer type 2 susceptibility protein sequence variant L1776* (human) | | | | | |
| | | | | |
|
PR:000063762 | breast cancer type 2 susceptibility protein sequence variant L1952* (human) | | | | | |
| | | | | |
|
PR:000060421 | breast cancer type 2 susceptibility protein sequence variant L2362* (human) | | | | | |
| | | | | |
|
PR:000062314 | breast cancer type 2 susceptibility protein sequence variant L2375* (human) | | | | | |
| | | | | |
|
PR:000064380 | breast cancer type 2 susceptibility protein sequence variant L2428* (human) | | | | | |
| | | | | |
|
PR:000062976 | breast cancer type 2 susceptibility protein sequence variant L2696* (human) | | | | | |
| | | | | |
|
PR:000061442 | breast cancer type 2 susceptibility protein sequence variant L2926* (human) | | | | | |
| | | | | |
|
PR:000063108 | breast cancer type 2 susceptibility protein sequence variant L553* (human) | | | | | |
| | | | | |
|
PR:000060575 | breast cancer type 2 susceptibility protein sequence variant L557* (human) | | | | | |
| | | | | |
|
PR:000062110 | breast cancer type 2 susceptibility protein sequence variant L638* (human) | | | | | |
| | | | | |
|
PR:000064410 | breast cancer type 2 susceptibility protein sequence variant L659* (human) | | | | | |
| | | | | |
|
PR:000061384 | breast cancer type 2 susceptibility protein sequence variant M1300* (human) | | | | | |
| | | | | |
|
PR:000062340 | breast cancer type 2 susceptibility protein sequence variant M2393* (human) | | | | | |
| | | | | |
|
PR:000062479 | breast cancer type 2 susceptibility protein sequence variant M965* (human) | | | | | |
| | | | | |
|
PR:000061987 | breast cancer type 2 susceptibility protein sequence variant Q1063* (human) | | | | | |
| | | | | |
|
PR:000063120 | breast cancer type 2 susceptibility protein sequence variant Q1124* (human) | | | | | |
| | | | | |
|
PR:000061249 | breast cancer type 2 susceptibility protein sequence variant Q1175* (human) | | | | | |
| | | | | |
|
PR:000062427 | breast cancer type 2 susceptibility protein sequence variant Q1429* (human) | | | | | |
| | | | | |
|
PR:000061760 | breast cancer type 2 susceptibility protein sequence variant Q1452* (human) | | | | | |
| | | | | |
|
PR:000063585 | breast cancer type 2 susceptibility protein sequence variant Q1551* (human) | | | | | |
| | | | | |
|
PR:000060653 | breast cancer type 2 susceptibility protein sequence variant Q1562* (human) | | | | | |
| | | | | |
|
PR:000063407 | breast cancer type 2 susceptibility protein sequence variant Q1658* (human) | | | | | |
| | | | | |
|
PR:000062947 | breast cancer type 2 susceptibility protein sequence variant Q1987* (human) | | | | | |
| | | | | |
|
PR:000060274 | breast cancer type 2 susceptibility protein sequence variant Q1998* (human) | | | | | |
| | | | | |
|
PR:000062357 | breast cancer type 2 susceptibility protein sequence variant Q2024* (human) | | | | | |
| | | | | |
|
PR:000063456 | breast cancer type 2 susceptibility protein sequence variant Q2159* (human) | | | | | |
| | | | | |
|
PR:000063673 | breast cancer type 2 susceptibility protein sequence variant Q2354* (human) | | | | | |
| | | | | |
|
PR:000064423 | breast cancer type 2 susceptibility protein sequence variant Q2731* (human) | | | | | |
| | | | | |
|
PR:000063961 | breast cancer type 2 susceptibility protein sequence variant Q2749* (human) | | | | | |
| | | | | |
|
PR:000060568 | breast cancer type 2 susceptibility protein sequence variant Q2823* (human) | | | | | |
| | | | | |
|
PR:000062861 | breast cancer type 2 susceptibility protein sequence variant Q2870* (human) | | | | | |
| | | | | |
|
PR:000064047 | breast cancer type 2 susceptibility protein sequence variant Q3026* (human) | | | | | |
| | | | | |
|
PR:000062574 | breast cancer type 2 susceptibility protein sequence variant Q3036* (human) | | | | | |
| | | | | |
|
PR:000060333 | breast cancer type 2 susceptibility protein sequence variant Q3066* (human) | | | | | |
| | | | | |
|
PR:000062501 | breast cancer type 2 susceptibility protein sequence variant Q373* (human) | | | | | |
| | | | | |
|
PR:000060946 | breast cancer type 2 susceptibility protein sequence variant Q499* (human) | | | | | |
| | | | | |
|
PR:000061434 | breast cancer type 2 susceptibility protein sequence variant Q609* (human) | | | | | |
| | | | | |
|
PR:000061418 | breast cancer type 2 susceptibility protein sequence variant Q73* (human) | | | | | |
| | | | | |
|
PR:000062240 | breast cancer type 2 susceptibility protein sequence variant Q754* (human) | | | | | |
| | | | | |
|
PR:000061616 | breast cancer type 2 susceptibility protein sequence variant Q893* (human) | | | | | |
| | | | | |
|
PR:000063497 | breast cancer type 2 susceptibility protein sequence variant R2318* (human) | | | | | |
| | | | | |
|
PR:000063290 | breast cancer type 2 susceptibility protein sequence variant R2401* (human) | | | | | |
| | | | | |
|
PR:000063256 | breast cancer type 2 susceptibility protein sequence variant R2520* (human) | | | | | |
| | | | | |
|
PR:000062558 | breast cancer type 2 susceptibility protein sequence variant R2625* (human) | | | | | |
| | | | | |
|
PR:000061909 | breast cancer type 2 susceptibility protein sequence variant R2659T (human) | | | | | |
| | | | | |
|
PR:000063206 | breast cancer type 2 susceptibility protein sequence variant R3128* (human) | | | | | |
| | | | | |
|
PR:000060984 | breast cancer type 2 susceptibility protein sequence variant S1013* (human) | | | | | |
| | | | | |
|
PR:000061227 | breast cancer type 2 susceptibility protein sequence variant S1064* (human) | | | | | |
| | | | | |
|
PR:000061793 | breast cancer type 2 susceptibility protein sequence variant S1099* (human) | | | | | |
| | | | | |
|
PR:000062573 | breast cancer type 2 susceptibility protein sequence variant S1271* (human) | | | | | |
| | | | | |
|
PR:000064536 | breast cancer type 2 susceptibility protein sequence variant S1385* (human) | | | | | |
| | | | | |
|
PR:000060887 | breast cancer type 2 susceptibility protein sequence variant S1442* (human) | | | | | |
| | | | | |
|
PR:000063901 | breast cancer type 2 susceptibility protein sequence variant S1630* (human) | | | | | |
| | | | | |
|
PR:000061081 | breast cancer type 2 susceptibility protein sequence variant S1720* (human) | | | | | |
| | | | | |
|
PR:000063952 | breast cancer type 2 susceptibility protein sequence variant S1882* (human) | | | | | |
| | | | | |
|
PR:000060285 | breast cancer type 2 susceptibility protein sequence variant S1968* (human) | | | | | |
| | | | | |
|
PR:000061675 | breast cancer type 2 susceptibility protein sequence variant S2052* (human) | | | | | |
| | | | | |
|
PR:000060654 | breast cancer type 2 susceptibility protein sequence variant S2095* (human) | | | | | |
| | | | | |
|
PR:000061867 | breast cancer type 2 susceptibility protein sequence variant S2372* (human) | | | | | |
| | | | | |
|
PR:000063042 | breast cancer type 2 susceptibility protein sequence variant S2695* (human) | | | | | |
| | | | | |
|
PR:000063123 | breast cancer type 2 susceptibility protein sequence variant S2835* (human) | | | | | |
| | | | | |
|
PR:000063689 | breast cancer type 2 susceptibility protein sequence variant S2978* (human) | | | | | |
| | | | | |
|
PR:000060602 | breast cancer type 2 susceptibility protein sequence variant S2994* (human) | | | | | |
| | | | | |
|
PR:000061329 | breast cancer type 2 susceptibility protein sequence variant S3231* (human) | | | | | |
| | | | | |
|
PR:000060390 | breast cancer type 2 susceptibility protein sequence variant S3245* (human) | | | | | |
| | | | | |
|
PR:000063079 | breast cancer type 2 susceptibility protein sequence variant S3291A (human) | | | | | |
| | | | | |
|
PR:000062152 | breast cancer type 2 susceptibility protein sequence variant S353* (human) | | | | | |
| | | | | |
|
PR:000061260 | breast cancer type 2 susceptibility protein sequence variant S450* (human) | | | | | |
| | | | | |
|
PR:000061243 | breast cancer type 2 susceptibility protein sequence variant S611* (human) | | | | | |
| | | | | |
|
PR:000064558 | breast cancer type 2 susceptibility protein sequence variant S648* (human) | | | | | |
| | | | | |
|
PR:000062904 | breast cancer type 2 susceptibility protein sequence variant S744* (human) | | | | | |
| | | | | |
|
PR:000061439 | breast cancer type 2 susceptibility protein sequence variant S76* (human) | | | | | |
| | | | | |
|
PR:000060858 | breast cancer type 2 susceptibility protein sequence variant S871* (human) | | | | | |
| | | | | |
|
PR:000062756 | breast cancer type 2 susceptibility protein sequence variant T2722I (human) | | | | | |
| | | | | |
|
PR:000062206 | breast cancer type 2 susceptibility protein sequence variant T2722R (human) | | | | | |
| | | | | |
|
PR:000064172 | breast cancer type 2 susceptibility protein sequence variant V1862* (human) | | | | | |
| | | | | |
|
PR:000061844 | breast cancer type 2 susceptibility protein sequence variant V323* (human) | | | | | |
| | | | | |
|
PR:000062320 | breast cancer type 2 susceptibility protein sequence variant W2586* (human) | | | | | |
| | | | | |
|
PR:000060891 | breast cancer type 2 susceptibility protein sequence variant W2626C (human) | | | | | |
| | | | | |
|
PR:000063448 | breast cancer type 2 susceptibility protein sequence variant W2626L (human) | | | | | |
| | | | | |
|
PR:000061049 | breast cancer type 2 susceptibility protein sequence variant W2970* (human) | | | | | |
| | | | | |
|
PR:000061347 | breast cancer type 2 susceptibility protein sequence variant W31* (human) | | | | | |
| | | | | |
|
PR:000064549 | breast cancer type 2 susceptibility protein sequence variant W31C (human) | | | | | |
| | | | | |
|
PR:000063262 | breast cancer type 2 susceptibility protein sequence variant W31R (human) | | | | | |
| | | | | |
|
PR:000061074 | breast cancer type 2 susceptibility protein sequence variant Y1714* (human) | | | | | |
| | | | | |
|
PR:000060343 | breast cancer type 2 susceptibility protein sequence variant Y1762* (human) | | | | | |
| | | | | |
|
PR:000062987 | breast cancer type 2 susceptibility protein sequence variant Y1894* (human) | | | | | |
| | | | | |
|
PR:000062900 | breast cancer type 2 susceptibility protein sequence variant Y2884* (human) | | | | | |
| | | | | |
|
PR:000061926 | breast cancer type 2 susceptibility protein sequence variant Y2977* (human) | | | | | |
| | | | | |
|
PR:000061491 | breast cancer type 2 susceptibility protein sequence variant Y2997* (human) | | | | | |
| | | | | |
|
PR:000060677 | breast cancer type 2 susceptibility protein sequence variant Y3006* (human) | | | | | |
| | | | | |
|
PR:000060630 | breast cancer type 2 susceptibility protein sequence variant Y803* (human) | | | | | |
| | | | | |
|
PR:000045545 | breast cancer type 2 susceptibility protein unphosphorylated 2 (human) | | | | | |
| | | | |
|
PR:P97929 | breast cancer type 2 susceptibility protein homolog (mouse) | | | | | |
| | | | |
|
PR:O35923 | breast cancer type 2 susceptibility protein homolog (rat) | | | | | |
| | | | |
|
PR:000035485 | breast cancer type 2 susceptibility protein phosphorylated 1 | | | | | |
| | | | | |
|
PR:000035486 | breast cancer type 2 susceptibility protein phosphorylated 1 (human) | | | | | |
| | | | |
|
PR:F1P3B2 | uncharacterized protein, BRCA2 translation product (chicken) | | | | | |
| | | | |
|
PR:Q54BU8 | uncharacterized protein, DDB_G0293414 translation product (Dictyostelium discoideum) | | | | | |